Tretinoin (Retin-A)


FDA Approved Indications:
  • Acne vulgaris
  • Avita, Retin-A, and Retin-A Micro are all indicated for the treatment of acne vulgaris
Prior authorization criteria:
  • Patient is > 30 years old AND
  • Diagnosis of acne vulgaris (supported by chart note documentation) AND
  • Failure to respond to the the following (supported by chart note documentation):
    • Prescription strength topical antibiotics (e.g., clindamycin, erythromycin).  NOTE: if patient has non-inflammatory acne, prescription strength topical antibiotics are not required; AND
    • Differin OTC; AND
    • For Retin-A Micro (topical tretinoin microsphere): in addition to failing the above medications, patients must also fail tretinoin non-mincrosphere

One Year


Last review date: July 15, 2020

WHA is closely monitoring the Coronavirus Disease 2019 (COVID-19). Learn more about COVID-19.